Inhibikase Back In Game As FDA Lifts Hold On Multiple System Atrophy Drug

 
• By Alaric DeArment
  
The FDA lifted a full clinical hold on Inhibikase's MSA program • Source: Shutterstock

More from Clinical Trials

More from R&D